Armstrong AW, Read C (2020) Pathophysiology, Clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945–1960
Article CAS PubMed Google Scholar
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, Global Psoriasis A (2020) National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 369:m1590-m
Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ et al (2016) Psoriasis Nature Reviews Disease Primers 2:16082
Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM (2017) Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol 76:377–390
Article PubMed PubMed Central Google Scholar
Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 64:66–73
Article CAS PubMed PubMed Central Google Scholar
Ran D, Cai M, Zhang X (2019) Genetics of psoriasis: a basis for precision medicine. Precision Clinical Medicine 2:120–130
Article PubMed PubMed Central Google Scholar
Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M et al (2017) Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun 8:15382
Article CAS PubMed PubMed Central Google Scholar
Rendon A, Schäkel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475
Article CAS PubMed PubMed Central Google Scholar
Swindell WR, Johnston A, Voorhees JJ, Elder JT, Gudjonsson JE (2013) Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics 14:527
Article CAS PubMed PubMed Central Google Scholar
Gudjonsson JE, Ding J, Johnston A, Tejasvi T, Guzman AM, Nair RP et al (2010) Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 130:1829–1840
Article CAS PubMed PubMed Central Google Scholar
Kabashima K, Honda T, Ginhoux F, Egawa G (2019) The immunological anatomy of the skin. Nat Rev Immunol 19:19–30
Article CAS PubMed Google Scholar
Ho AW, Kupper TS (2019) T cells and the skin: from protective immunity to inflammatory skin disorders. Nat Rev Immunol 19:490–502
Article CAS PubMed Google Scholar
Belkaid Y, Harrison OJ (2017) Homeostatic immunity and the microbiota. Immunity 46:562–576
Article CAS PubMed PubMed Central Google Scholar
Quaresma JAS (2019) Organization of the skin immune system and compartmentalized immune responses in infectious diseases. Clin Microbiol Rev 32:e00034-e118
Article CAS PubMed PubMed Central Google Scholar
Clark RA (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130:362–370
Article CAS PubMed Google Scholar
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M (2019) Risk factors for the development of psoriasis. Int J Mol Sci 20:4347
Article CAS PubMed PubMed Central Google Scholar
Sun L, Liu W, Zhang L-J (2019) The role of toll-like receptors in skin host defense, psoriasis, and atopic dermatitis. J Immunol Res 2019:1824624
Article PubMed PubMed Central Google Scholar
Zhang LJ, Sen GL, Ward NL, Johnston A, Chun K, Chen Y et al (2016) Antimicrobial peptide LL37 and MAVS signaling drive interferon-β production by epidermal keratinocytes during skin injury. Immunity 45:119–130
Article CAS PubMed PubMed Central Google Scholar
Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B et al (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564–569
Article CAS PubMed Google Scholar
Liu S, Wu F, Wu Z, Li Y, Zhang S, Yu N (2019) IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: a potential role in injury-amplified psoriatic inflammation. Exp Dermatol 28:233–239
Article CAS PubMed Google Scholar
Re F, Strominger JL (2001) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 276:37692–37699
Article CAS PubMed Google Scholar
Ramirez-Carrozzi V, Sambandam A, Luis E, Lin Z, Jeet S, Lesch J et al (2011) IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol 12:1159–1166
Article CAS PubMed Google Scholar
Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46:1–23
Krueger JG (2012) Hiding under the skin: a welcome surprise in psoriasis. Nat Med 18:1750–1751
Article CAS PubMed Google Scholar
Wang A, Fogel AL, Murphy MJ, Panse G, McGeary MK, McNiff JM et al (2021) Cytokine RNA in situ hybridization permits individualized molecular phenotyping in biopsies of psoriasis and atopic dermatitis. JID Innovations 1:100021
Article PubMed PubMed Central Google Scholar
Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871–884
Article CAS PubMed Google Scholar
Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE (2014) Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling. Br J Dermatol 171:97–107
Article CAS PubMed PubMed Central Google Scholar
Li B, Tsoi LC, Swindell WR, Gudjonsson JE, Tejasvi T, Johnston A et al (2014) Transcriptome analysis of psoriasis in a large case–control sample: RNA-seq provides insights into disease mechanisms. J Investig Dermatol 134:1828–1838
Article CAS PubMed Google Scholar
Natsuaki Y, Egawa G, Nakamizo S, Ono S, Hanakawa S, Okada T et al (2014) Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin. Nat Immunol 15:1064–1069
Article CAS PubMed Google Scholar
Mee JB, Johnson CM, Morar N, Burslem F, Groves RW (2007) The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol 171:32–42
Article CAS PubMed PubMed Central Google Scholar
Cai Y, Xue F, Quan C, Qu M, Liu N, Zhang Y et al (2019) A critical role of the IL-1β-IL-1R signaling pathway in skin inflammation and psoriasis pathogenesis. J Invest Dermatol 139:146–156
Comments (0)